ELMED Launches Expanded Aquaculture Probiotic Portfolio

ELMED Life Sciences is proud to announce the commercial launch of three new aquaculture probiotic formulations developed in collaboration with leading fish-farming operations across South and Southeast Asia. These products are the result of 18 months of rigorous field trials encompassing over 6 million target animals.

New Product Highlights

• AquaVita SH — Shrimp health blend targeting AHPND/EMS prevention, gut microbiome balance, and FCR improvement. Field trials demonstrated 38% reduction in early mortality events.
• AquaVita TL — Tilapia-specific formulation supporting growth promotion and Streptococcus challenge resistance. Average weight gain improvement of 14% versus control ponds.
• AquaVita SL — Salmon gut-health and stress-resilience blend designed for recirculating aquaculture systems (RAS) and sea-cage environments.

Availability

All three formulations are available in bulk powder and water-dispersible granule formats for direct water application or feed incorporation. Minimum order quantities start at 25 kg. Regulatory dossiers are available for Vietnam, India, Thailand, Indonesia, and Norway.

The aquaculture sector is under enormous pressure to reduce antibiotic dependency. Our new range gives farmers a scientifically validated, commercially viable alternative. — ELMED Aquaculture Lead